Avaliação da imunidade celular nos pacientes Co-Infectados pelo vírus da hepatite C e vírus da imunodeficiência humana

Tovo, Cristiane Valle; Santos, Diogo Edele dos; Mattos, Angelo Zambam de; Mattos, Angelo Alves de; Santos, Breno Riegel; Galperim, Bruno.
Arq. gastroenterol ; 44(2): 113-117, abr.-jun. 2007. tab
Artículo en Portugués | LILACS | ID: lil-465709

Documentos relacionados

  1. [Evaluation of the cellular immunity in patients coinfected by the hepatitis C virus and the human immunodeficiency virus].
  2. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
  3. Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection.
  4. High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections.
  5. Assessment of the Prevalence of Non-Organ-Specific Autoantibodies in Egyptian Patients with HCV.
  6. Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
  7. Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
  8. CD4+ T-cell recovery in HIV/hepatitis C co-infected patients following successful hepatitis C treatment.
  9. HIV co-infection accelerates decay of humoral responses in spontaneous resolvers of HCV infection.
  10. CD4/CD8 ratio predicts the cellular immune response to acute hepatitis C in HIV-coinfected adults.